Contact FreedomWorks

111 K Street NE
Suite 600
Washington, DC 20002

  • Toll Free 1.888.564.6273
  • Local 202.783.3870
WATCH NOWTrump's SCOTUS List, Football Is Back, & Laundry Problems | Pardon the DisruptionWatch Here
""
""
https://fw-d7-freedomworks-org.s3.amazonaws.com/styles/thumbnail/s3/field/image/RACReview-Thumbnail_0_0.png?itok=hy28BVLC
Blog

Regulatory Action Center Review - July 16, 2020

LIVE @WhiteHouse: Federal Affairs @DanielSavickas Assesses President @realDonaldTrump's Successful Deregulatory Agenda Before the Election! #ampFW https://t.co/1wJIGkdO4z https://t.co/QwzOQufZt9 pic.twitter.com/oGY617rzXE

07/16/2020
""
""
https://fw-d7-freedomworks-org.s3.amazonaws.com/styles/thumbnail/s3/field/image/IQOS.jpg?itok=wf6SRBiJ
Press Release

FreedomWorks Foundation Statement in Response to FDA Approving the Marketing of IQOS as Modified Risk Tobacco Product

WASHINGTON, D.C. -- In response to the Food and Drug Administration (FDA) authorizing Philip Morris to market its IQOS heating system as a modified risk tobacco product (MRTP), Dan Savickas, FreedomWorks Foundation’s Regulatory Policy Manager commented:

07/07/2020